Current Smoking, Not Duration of Remission, Delays Crohn's Disease Relapse Following Azathioprine Withdrawal

被引：16
|
作者：
Sokol, Harry [1 ]
Seksik, Philippe [1 ]
Nion-Larmurier, Isabelle [1 ]
Vienne, Ariane [1 ]
Beaugerie, Laurent [1 ]
Cosnes, Jacques [1 ]
机构：
[1] Univ Paris 06, St Antoine Hosp, AP HP, Dept Gastroenterol & Nutr, Paris, France
来源：
INFLAMMATORY BOWEL DISEASES | 2010年 / 16卷 / 03期
关键词：
D O I：
10.1002/ibd.20981
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：362 / 363
页数：2
相关论文
共 50 条
  • [1] Relapse Rate Following Azathioprine Withdrawal in Maintaining Remission for Crohn's Disease: A Meta-Analysis
    French, Helen
    Dalzell, A. Mark
    Srinivasan, Ramesh
    El-Matary, Wael
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (07) : 1929 - 1936
  • [2] Relapse Rate Following Azathioprine Withdrawal in Maintaining Remission for Crohn’s Disease: A Meta-Analysis
    Helen French
    A. Mark Dalzell
    Ramesh Srinivasan
    Wael El-Matary
    [J]. Digestive Diseases and Sciences, 2011, 56 : 1929 - 1936
  • [3] Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
    Treton, Xavier
    Bouhnik, Yoram
    Mary, Jean-Yves
    Colombel, Jean-Frederic
    Duclos, Bernard
    Soule, Jean-Claude
    Lerebours, Eric
    Cosnes, Jacques
    Lemann, Marc
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (01) : 80 - 85
  • [4] Azathioprine Withdrawal Is Cost-Effective in Patients with Crohn’s Disease in Remission on Infliximab and Azathioprine
    Gaurav Syal
    Gil Y. Melmed
    Christopher V. Almario
    Brennan M. R. Spiegel
    [J]. Digestive Diseases and Sciences, 2023, 68 : 404 - 413
  • [5] Azathioprine Withdrawal Is Cost-Effective in Patients with Crohn's Disease in Remission on Infliximab and Azathioprine
    Syal, Gaurav
    Melmed, Gil Y. Y.
    Almario, Christopher V. V.
    Spiegel, Brennan M. R.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (02) : 404 - 413
  • [6] Azathioprine withdrawal in patients with Crohn's disease (CD) maintained on prolonged remission under treatment is associated with a high risk of relapse
    Treton, X
    Bouhnik, Y
    Mary, JY
    Colombel, JF
    Duclos, B
    Soule, JC
    Modigliani, R
    Lemann, M
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A113 - A113
  • [7] Spontaneous Regression of Colonic Lymphoma Following Infliximab and Azathioprine Withdrawal in Patients With Crohn's Disease
    Flynn, Ann D.
    Azar, Jose M.
    Chiorean, Michael V.
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (05) : E69 - E70
  • [8] Spontaneous Regression of Colonic Lymphoma Following Infliximab and Azathioprine Withdrawal in Patients with Crohn's Disease
    Flynn, Ann
    Azar, Jose
    Chiorean, Michael
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S502 - S502
  • [9] Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease:: increased relapse rate the following year
    Vilien, M
    Dahlerup, JF
    Munck, LK
    Norregaard, P
    Gronbæk, K
    Fallingborg, J
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (11) : 1147 - 1152
  • [10] Smoking, azathioprine, and clinical course in Crohn's disease - Reply
    Cosnes, J
    Carbonnel, F
    Beaugerie, L
    Gendre, JP
    [J]. GASTROENTEROLOGY, 1996, 111 (04) : 1161 - 1162
12345